Two in Three Early Breast Cancer Patients Fear Recurrence, Yet Low-Risk Assumptions Deter Conversations
byAt a Glance: One in six HR+/HER2- early breast cancer patients (Stage II & III) face risk of recurrence within 3 years¹ Novartis Malaysia…
At a Glance: One in six HR+/HER2- early breast cancer patients (Stage II & III) face risk of recurrence within 3 years¹ Novartis Malaysia…
This October, in conjunction with Breast Cancer Awareness Month, HOMESOY continues its commitment to women’s health with ‘Stop That Dot Together’, the sequel to…